GMP Certified / Paclitaxel Injection 100mg/16.7ml

Quality Standard:	USP, Bp
Factory Certified:	GMP
Ctd Status:	Available
Transport Package:	Sea Transportation
Specification:	100mg/16.7ml
Trademark:	Sinolead

Samples:	US$ 0.01/Piece 1 Piece(Min.Order) \| Request Sample

Customization:	Available \| Customized Request

Contact Supplier

Contact Now

Inquiry Basket

Guangzhou Sinolead Biotech Co., Ltd.

Gold Member Since 2018

Suppliers with verified business licenses

Audited Supplier

Rating: 3.0/5

Manufacturer/Factory, Trading Company, Group Corporation

Product Description

Company Info.

Basic Info.

Model NO.

injection

Origin

China

Production Capacity

100, 000, 000 Per Year

Product Description

Product Description

Generic name	Paclitaxel Injection
Strength	100mg/16.7ml
Standard	BP
Shelf life	2 years
Packing form	1 vial/box

Value-added services:
Packaging design by our team
Registration service by our team
Registration dossier available by our team
-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------

Product name:
Paclitaxel Injection 100mg/16.7ml

Character:
This product is colorless or yellowish viscous liquid.

Indications:
First-line and subsequent treatment of advanced ovarian cancer.
Adjuvant therapy after standard doxorubicin-containing chemotherapy in patients with lymph node positive breast cancer.
Patients with metastatic breast cancer who have failed combination chemotherapy or have recurred within six months of adjuvant chemotherapy.
First-line treatment for patients with non-small cell lung cancer.
Second-line treatment of AIDS-associated karnosarcoma.

Pharmacology and toxicology:
Taxol (paclitaxel) injection Paclitaxel is a novel anti-microtubule agent. Stabilizing the microtubules by promoting the combination of tubulin dimers and preventing their depolymerization inhibits the normal dynamic recombination of the micropipe network, which is essential for intermitotic and mitotic cell function. In addition, paclitaxel can cause abnormal arrangement of microtubule "bundles" throughout the cell cycle and mitosis when multiple stellates are produced, affecting the division of tumor cells.
The carcinogenicity of taxol (paclitaxel) has not been studied. The mutagenicity of Taxitin has been demonstrated in vitro (human lymphocyte chromosome aberration) and in vivo (mouse micronucleus) test systems in mammals, however, Taxitin does not induce mutation in Ames test or CHO/HGPRT gene mutagenicity test.

Storage:
Store under 25ºC away from light.
GMP Certified / Paclitaxel Injection 100mg/16.7ml